Further, the level of fibroblast growth factor 19 (FGF19), as a downstream molecule of intestinal FXR signal, is significantly decreased in GDM and exhibits a negative correlation with insulin resistance [31]. The gene discussed is NR1H4; the disease is Insulin resistance.